April 30, 2013
| Alexandra Mulvey
From April 25-27, more than 160 participated in our annual conference to bring together industry and academia to tackle the most relevant issues in cancer immunotherapy development today. This year’s event focused on practical implementation of combination therapies.
Cancer Immunotherapy Consortium, clinical trials, collaboration, immunotherapy